Source: Index Values - S&P Dow Jones Indices; Forex Rate - RBI/Thomson Reuter and MOAMC; Performance Data as of Close of 31-Oct-2006 to 31-Oct-2021. S&P 500 Index values are adjusted for one day lag movement due to difference in time zones. ^ denotes the index currency conversion. Performance results may have many inherent limitations and no representation is being made that any investor will, or is likely to achieve the performance similar to that shown. Past performance may or may not be sustained in future. The above table/graph is used to explain the concept and is for illustration purpose only. It should not be used for development or implementation of any investment strategy.
Source: Index Values - NASDAQ; Forex Rate - RBI/Thomson Reuter and MOAMC; Performance Data as of Close of 31-Oct-2006 to 31-Oct-2021. NASDAQ 100 Index values are adjusted for one day lag movement due to difference in time zones. ^ denotes the index currency conversion. Performance results may have many inherent limitations and no representation is being made that any investor will, or is likely to achieve the performance similar to that shown. Past performance may or may not be sustained in future. The above table/graph is used to explain the concept and is for illustration purpose only. It should not be used for development or implementation of any investment strategy.
Source: Index Values - MSCI; Forex Rate - RBI/Thomson Reuter and MOAMC; Performance Data as of Close of 31-Oct-2006 to 31-Oct-2021. ^ denotes the index currency conversion. Performance results may have many inherent limitations and no representation is being made that any investor will, or is likely to achieve the performance similar to that shown. Past performance may or may not be sustained in future. The above table/graph is used to explain the concept and is for illustration purpose only. It should not be used for development or implementation of any investment strategy.
Source: Index Values - S&P Dow Jones Indices, Nasdaq; Forex Rate - RBI/Thomson Reuter and MOAMC; Performance Data as of Close of 31-Dec-2006 to 31-Dec-2021. Index values are adjusted for one day lag movement due to difference in time zones. ^ denotes the index currency conversion. Performance results may have many inherent limitations and no representation is being made that any investor will, or is likely to achieve the performance similar to that shown. Past performance may or may not be sustained in future. The above table/graph is used to explain the concept and is for illustration purpose only. It should not be used for development or implementation of any investment strategy.
Data as on 31 January 2022.
About S&P 500 Index
The S&P 500 Index is designed to measure the performance of leading 500 companies listed in United States and covers approximately 80% of available market capitalization.
Type of scheme
An open ended scheme replicating/tracking S&P 500 TR Index
Exit Load
1% if redeemed on or before 15 days from allotment date, Nil if redeemed after 15 days from allotment date
Benchmark
S&P 500 TR Index
Investment Objective
The Scheme seeks investment return that corresponds to the performance of S&P 500 Index subject to tracking error. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved
Total Expense ratio
Regular - 1.09%
Direct - 0.52%
Minimum application amount
Lumpsum and SIP- Rs 500 in multiples of Re. 1/- thereafter
About Nasdaq 100 Index
The Nasdaq 100 Index is designed to measure the performance of 100 of the largest non-financial companies listed on The Nasdaq Stock Market, based on market capitalization
Type of scheme
An open ended scheme replicating/tracking Nasdaq 100 TR Index
Exit Load
Nil
Benchmark
Nasdaq 100 TR Index
Investment Objective
The Scheme seeks investment returns by investing in units of Motilal Oswal Nasdaq 100 ETF subject to tracking error. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Minimum application amount
Lumpsum and SIP- Rs 500 in multiples of Re. 1/- thereafter
Total Expense ratio
Regular - 0.50%
Direct - 0.10%
About MSCI EAFE Top 100 Select Index
The MSCI EAFE Top 100 Select Index is designed to measure the performance of the top 100 companies, selected from 10 large developed markets, out of MSCI EAFE Index.
Type of scheme
An open ended scheme replicating/tracking MSCI EAFE Top 100 Select Index
Exit Load
1% if redeemed on or before 15 days from allotment date, Nil if redeemed after 15 days from allotment date
Benchmark
MSCI EAFE Top 100 Select Index
Investment objective
The investment objective is to generate long term capital appreciation by investing in securities of MSCI EAFE Top 100 Select Index subject to tracking error. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Minimum application amount
Lumpsum and SIP: Rs 500 & in multiples of Re. 1/- thereafter
Indicative Total Expense Ratio
Regular TER - 0.50%
Direct - 1.00%
Type of scheme
An open ended scheme replicating/tracking Nasdaq Q-50 TR Index
Continuous Offer
NSE/BSE: Investors can buy/sell units of the Scheme in
round lot of 1 unit and in multiples thereof.
Directly with Mutual Fund: Buy/sell units of the Scheme unit
size of 6,00,000 units and in multiples thereafter.
Benchmark
Nasdaq Q-50 TR Index
Launch Date
23-Dec-2021
Investment objective
The investment objective is to generate long term capital appreciation by investing in securities of Nasdaq Q-50 Index subject to tracking error. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.
Exit Load
Nil
Fund Manager
Mr. Ankush Sood &
Mr. Abhiroop Mukherjee (for debt component)
Total Expense Ratio
Regular- 0.42%
Product Labeling | Scheme Riskometer | Benchmark Riskometer S&P 500 TRI (INR) |
Name of the scheme Motilal Oswal S&P 500 Index Fund (An open ended scheme replicating / tracking S&P 500 Index) |
||
This product is suitable for investors who are seeking 1) Return that corresponds to the performance of S&P 500 Index subject to tracking error 2) Investment in equity securities of S&P 500 Index |
||
Investors understand that their principal will be at Very High risk |
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Product Labeling | Scheme Riskometer | Benchmark Riskometer NASDAQ 100 TRI (INR) |
Name of the scheme Motilal Oswal Nasdaq 100 Fund of Fund (An open ended fund of fund scheme investing in Motilal Oswal Nasdaq 100 ETF) |
||
This product is suitable for investors who are seeking 1) Long term capital appreciation 2) Return that corresponds generally to the performance of the Scheme, Motilal Oswal Nasdaq 100 ETF through investment in units of Motilal Oswal Nasdaq 100 ETF |
||
Investors understand that their principal will be at Very High risk |
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Product Labeling | Scheme Riskometer | Benchmark Riskometer MSCI EAFE Top 100 Select Index |
Name of the scheme Motilal Oswal MSCI EAFE Top 100 Select Index Fund (An open ended scheme replicating/ tracking MSCI EAFE Top 100 Select Index) |
||
This product is suitable for investors who are seeking 1) Returns that corresponds to the performance of MSCI EAFE Top 100 Select Index, subject to tracking error. 2) Long term capital growth. |
||
Investors understand that their principal will be at Very High risk |
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.
Product Labeling | Scheme Riskometer | Benchmark Riskometer NASDAQ Q-50 Total Return Index |
Name of the scheme Motilal Oswal Nasdaq Q 50 ETF (An open ended scheme replicating/tracking Nasdaq Q-50 TR Index) |
||
This product is suitable for investors who are seeking 1) Return that corresponds generally to the performance of the NASDAQ Q-50 TR Index subject to tracking error and forex movement. 2) Long term capital growth |
||
Investors understand that their principal will be at Very High risk |
*Investors should consult their financial advisers if in doubt about whether the product is suitable for them.